Weekly Weight-Loss Shot A ‘Game Changer In Obesity Medicine’
View Source | September 12, 2022 1:05 pm
Continue to Article
- A new weight-loss shot is being hailed as a “game changer” — with the potential to cut diabetes risk by 50% and “fight obesity as a disease” for the first time, according to a new study.
- The research, conducted by the University of Alabama, found that weekly jabs of the drug semaglutide in overweight and obese research participants caused an average weight loss of 37 pounds.
- “We have not seen this degree of weight loss with any previous medication,” said lead study author Dr. Timothy Garvey in a statement.
- “More than 50% of trial participants are losing 15% of their body weight, and anywhere between a third and 40% of participants are losing 20% of their body weight.”
Share This Article: